Symptoms and Consequences: Symptoms may range from fluid retention and swelling to decreased urine output
Supplements are not intended as a substitute for a varied diet
At Formation we use only human-grade compounds from licensed pharmacies, and we hold SSRP and ISSCA certification for working with these molecules
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
December 2, 2025: Australia Regulators Add Risk of Suicidal, Self-Harm Thoughts to Trulicity Label Patients who took Trulicity have reported experiencing thoughts of harming themselves or ending their lives, the Therapeutic Goods Administration warns
